122 related articles for article (PubMed ID: 25871618)
21. NKX6-1 Is a Less Sensitive But Specific Biomarker of Chromophobe Renal Cell Carcinoma.
Xie B; Tong K; Yang J; Wang T; Cheng L; Zeng S; Hu Z
Am J Surg Pathol; 2022 Jun; 46(6):809-815. PubMed ID: 35256556
[TBL] [Abstract][Full Text] [Related]
22. PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
Haynes CM; Sangoi AR; Pai RK
Cancer Cytopathol; 2011 Jun; 119(3):193-201. PubMed ID: 21328566
[TBL] [Abstract][Full Text] [Related]
23. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
[TBL] [Abstract][Full Text] [Related]
24. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.
Hoskoppal D; Epstein JI; Gown AM; Arnold Egloff SA; Gordetsky JB; Shi CJ; Giannico GA
Histopathology; 2020 Mar; 76(4):550-559. PubMed ID: 31595536
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
Yang Z; Klimstra DS; Hruban RH; Tang LH
Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A
Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins.
Le Gall F; Vallet VS; Thomas D; De Monti M; Duval J; Ramee MP
Pathol Res Pract; 1997; 193(3):179-85. PubMed ID: 9198103
[TBL] [Abstract][Full Text] [Related]
28. Phosphohistone H3 and Ki-67 labeling indices in cytologic specimens from well-differentiated neuroendocrine tumors of the gastrointestinal tract and pancreas: a comparative analysis using automated image cytometry.
Fung AD; Cohen C; Kavuri S; Lawson D; Gao X; Reid MD
Acta Cytol; 2013; 57(5):501-8. PubMed ID: 24021213
[TBL] [Abstract][Full Text] [Related]
29. Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas.
Fendrich V; Ramerth R; Waldmann J; Maschuw K; Langer P; Bartsch DK; Slater EP; Ramaswamy A; Rothmund M
Endocr Relat Cancer; 2009 Jun; 16(2):613-22. PubMed ID: 19240184
[TBL] [Abstract][Full Text] [Related]
30. A synchronous pancreatic neuroendocrine tumor and duodenal gastrointestinal stromal tumor.
Ueda K; Hijioka M; Lee L; Igarashi H; Niina Y; Osoegawa T; Nakamura K; Takahashi S; Aishima S; Ohtsuka T; Takayanagi R; Ito T
Intern Med; 2014; 53(21):2483-8. PubMed ID: 25366007
[TBL] [Abstract][Full Text] [Related]
31. Duodenal gastrointestinal stromal tumor with epithelioid and neural features mimicking a primary pancreas head neuroendocrine tumor.
Slavik T; du Plessis J; Sparaco A; van der Merwe SW
Pancreas; 2014 Apr; 43(3):482-3. PubMed ID: 24622084
[No Abstract] [Full Text] [Related]
32. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids.
Saqi A; Alexis D; Remotti F; Bhagat G
Am J Clin Pathol; 2005 Mar; 123(3):394-404. PubMed ID: 15716236
[TBL] [Abstract][Full Text] [Related]
33. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine Tumor of the Minor Duodenal Papilla: An Unusual Cause of Pancreaticoduodenectomy.
Virgilio E; La Gumina G; Tozzi F; Marrero YC; Ziparo V; Cavallini M
Am Surg; 2016 Nov; 82(11):1145-1148. PubMed ID: 28206947
[No Abstract] [Full Text] [Related]
35. Cdx2 as a marker for neuroendocrine tumors of unknown primary sites.
Erickson LA; Papouchado B; Dimashkieh H; Zhang S; Nakamura N; Lloyd RV
Endocr Pathol; 2004; 15(3):247-52. PubMed ID: 15640551
[TBL] [Abstract][Full Text] [Related]
36. [Management of duodenal-pancreatic endocrine tumors].
Partensky C
J Chir (Paris); 2000 Jun; 137(3):142-50. PubMed ID: 10915980
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Features of Primary Neuroendocrine Tumors of Gastrointestinal/Pancreatobiliary Tract With Emphasis on High-Grade (Grade 3) Well-Differentiated Neuroendocrine Tumors.
Hashmi AA; Ali J; Yaqeen SR; Ahmed O; Asghar IA; Irfan M; Asif MG; Edhi MM; Hashmi S
Cureus; 2021 Jan; 13(1):e12640. PubMed ID: 33585126
[TBL] [Abstract][Full Text] [Related]
38. Detection of pancreatic neuroendocrine tumors: 23 years of experience.
Varas-Lorenzo MJ; Cugat E; Capdevila J; Sánchez-Vizcaíno Mengual E
Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):18-25. PubMed ID: 29858120
[TBL] [Abstract][Full Text] [Related]
39. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
40. Cyst fluid carcinoembryonic antigen in the investigation of cystic neuroendocrine tumors of the pancreas.
Croagh D; Forde C; Boulton R; Mahon B
Gastrointest Endosc; 2011 Dec; 74(6):1413-6. PubMed ID: 22136785
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
